These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2993696)

  • 1. [Evaluation of the malignancy of breast carcinoma using flow cytometry].
    Ueki H; Abe R; Kimura M; Kasai M
    Gan No Rinsho; 1985 Jul; 31(8):929-32. PubMed ID: 2993696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
    Ewers SB; Långström E; Baldetorp B; Killander D
    Cytometry; 1984 Jul; 5(4):408-19. PubMed ID: 6468179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution.
    Weiss H; Kunde D; Streller B
    Arch Geschwulstforsch; 1986; 56(5):373-9. PubMed ID: 3021084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of image cytometry DNA parameters in tissue sections from breast and gastric cancers.
    Haroske G; Kunze KD; Theissig F
    Anal Cell Pathol; 1991 Jan; 3(1):11-24. PubMed ID: 1848088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular pH, esterase activity, and DNA measurements of human lung carcinomas by flow cytometry.
    Liewald F; Demmel N; Wirsching R; Kahle H; Valet G
    Cytometry; 1990; 11(3):341-8. PubMed ID: 2340771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry and cytomorphology in primary resectable breast cancer.
    Bedrossian CW; Raber M; Barlogie B
    Anal Quant Cytol; 1981 Jun; 3(2):112-6. PubMed ID: 6266303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
    Hedley DW; Rugg CA; Gelber RD
    Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental and clinical study on flow cytometric DNA analysis of human breast carcinoma].
    Nakamura A
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):737-46. PubMed ID: 3412305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative DNA analysis of breast cancer by flow cytometry and image analysis.
    Borgiani L; Cogorno P; Toso F; Gallo L; Buccaran G; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):356-9. PubMed ID: 7535909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of carcinoembryonic antigen (CEA) in breast carcinoma using an immunohistochemical method: morpho-functional evaluations and diagnostic uses].
    Lanzafame S; Puzzo L; Bartoloni G
    Pathologica; 1985; 77(1050):373-84. PubMed ID: 3010221
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
    Bogatyrev VN; Ermilova VD; Petrova AS
    Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical classification of nonpalpable breast carcinoma.
    Fallenius A; Svane G; Auer G; Caspersson TO
    Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas.
    Haag D; Feichter G; Goerttler K; Kaufmann M
    Cytometry; 1987 Jul; 8(4):377-85. PubMed ID: 3622159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aneuploidy and proliferative activity in breast cancer (flow-cytometric investigation)].
    Bychkova NV; Pozharisskiĭ KM
    Vopr Onkol; 1997; 43(2):171-5. PubMed ID: 9214117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.